Meanwhile, Prof Peter Openshaw, a member of the New and Emerging Respiratory Virus Threats Advisory Group (Nervtag), told BBC Radio 4’s Broadcasting House programme that vaccine transmission data was “looking really good”, but scientists still needed to estimate by how much the vaccine interrupted transmission.
